Spero Therapeutics Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio3.42
P/S Ratio1.170.751.6728.3556.50
P/B Ratio1.220.731.185.863.99
Price/Tangible Book1.220.731.185.863.99
Enterprise Value Ratios
EV/Revenue0.8621.9843.73
Profitability & Returns
Return on Equity (ROE)-0.90%0.25%-0.57%-0.81%-0.76%
Return on Assets (ROA)-0.31%0.11%-0.13%-0.34%-0.38%
Return on Invested Capital (ROIC)-4.31%5.02%-16.59%-14.32%
Return on Capital Employed (ROCE)-1.18%0.18%-0.30%-0.58%-0.57%
Leverage & Solvency Ratios
Debt/Equity0.090.050.090.630.06
Debt/EBITDA0.19
Liquidity Ratios
Current Ratio2.193.535.258.469.70
Quick Ratio2.153.425.097.989.28
Efficiency Ratios
Asset Turnover0.330.680.360.110.07
Yield & Distribution Ratios
Earnings Yield-1.22%0.29%-0.52%-0.17%-0.15%
FCF Yield-0.42%-0.42%-0.09%-0.12%-0.16%
Buyback Yield-0.02%-0.41%-0.22%-0.38%-0.23%